We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Urine Specimen Collection System Improves Diagnostic Accuracy and Efficiency

By LabMedica International staff writers
Posted on 26 Feb 2026

Urine testing is a critical, non-invasive diagnostic tool used to detect conditions such as pregnancy, urinary tract infections, metabolic disorders, cancer, and kidney disease. More...

However, contaminated or improperly collected urine samples can lead to incorrect results, delayed care, or inappropriate treatment. One study found that nearly 44 percent of patients with contaminated urine cultures received unnecessary antibiotic therapy, highlighting the clinical impact of preanalytical errors. Now, a newly introduced three-tube urine collection system aims to preserve specimen integrity, reduce contamination risk,s and enable broader testing from a single sample, minimizing repeat collections and improving workflow efficiency.

BD (Becton, Dickinson and Company) (Franklin Lakes, NJ, USA) has launched the BD Vacutainer Urine Complete Cup Kit that preserves specimen quality, streamlines testing, and helps reduce repeat collections to support better patient care. Designed as a closed-system, the three-tube collection solution expands testing capabilities from one urine specimen while supporting automated laboratory workflows.

The kit includes a sterile urine cup with an integrated transfer device, a tube for culture and sensitivity testing to detect bacteria or fungi, a tube for urinalysis to assess general health and disease markers, a discard tube without additives, and a castile wipe for patient preparation. The innovative third-tube design allows clinicians to perform additional testing without manually transferring urine or collecting a new specimen.

The kit supports broader diagnostic evaluation while reducing healthcare worker exposure and lowering contamination risks associated with manual transfers. Enabling multiple tests from a single collection, it helps decrease the likelihood of repeat patient sampling and associated workflow disruptions. Closed-system solutions such as those in the BD Vacutainer Urine Collection portfolio are intended to minimize preanalytical errors and improve the reliability of laboratory results. The system is available in the United States with both Hemogard and conventional stoppered tubes and is compatible with a wide range of diagnostic equipment.

By streamlining specimen management, the collection kit is designed to enhance diagnostic accuracy and support timely treatment decisions. It can be integrated into existing laboratory processes and automated workflows, helping healthcare facilities improve efficiency across the urine specimen management continuum. The expanded testing capability from a single specimen can reduce contamination-related errors and unnecessary antibiotic use, contributing to safer and more effective patient care.

"Improving diagnostic accuracy starts long before a sample reaches the lab," said Bridget Bagnato, worldwide president of Specimen Management at BD. "This kit reflects the innovation we deliver to help clinicians determine effective treatment options through more accurate diagnosis and ultimately support better patient management."

Related Links:
BD 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Immunoassay Analyzer
Procise DX
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Molecular Diagnostics

view channel
Image Credit: 123RF

Genetic Testing Program Helps Uncover Inherited Risk in Pediatric Cancer

Inherited cancer risk can affect children, adolescents and young adults, but it may not always be apparent from tumor type or family history alone. Some cancer syndromes require specialized expertise and... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.